Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Allain

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
Therapie|October 17, 1998
[Balance sheet of tolerance-efficacy on the use of tacrine in 100 cases of Alzheimer's disease]M C Estadieu, C Machou, P Berthezène, et al.
Nature Communications|April 10, 2019
Specific inhibition of splicing factor activity by decoy RNA oligonucleotidesPolina Denichenko, Maxim Mogilevsky, Antoine Cléry, et al.
Revue Neurologique|April 2, 2002
[Long-term treatment of Alzheimer's disease: followup of a cohort of 255 patients treated with lacrine for four years]B F Michel, M C Estadieu, C Gueriot, et al.
European Journal of Neurology|November 29, 2013
A double-blind, placebo-controlled, enriched population study of tacrine in patients with Alzheimer's diseaseF Forette, T Hoover, S Gracon, et al.
Revue Neurologique|October 26, 2005
[Consensus statement on severe dementia]B Vellas, S Gauthier, H Allain, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2005
[Consensus statement on severe dementia]B Vellas, S Gauthier, H Allain, et al.
The Journal of Nutrition, Health & Aging|October 14, 2005
Consensus statement on dementia of Alzheimer type in the severe stageB Vellas, S Gauthier, H Allain, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Therapie|October 17, 1998
[Balance sheet of tolerance-efficacy on the use of tacrine in 100 cases of Alzheimer's disease]M C Estadieu, C Machou, P Berthezène, et al.
Nature Communications|April 10, 2019
Specific inhibition of splicing factor activity by decoy RNA oligonucleotidesPolina Denichenko, Maxim Mogilevsky, Antoine Cléry, et al.
Revue Neurologique|April 2, 2002
[Long-term treatment of Alzheimer's disease: followup of a cohort of 255 patients treated with lacrine for four years]B F Michel, M C Estadieu, C Gueriot, et al.
European Journal of Neurology|November 29, 2013
A double-blind, placebo-controlled, enriched population study of tacrine in patients with Alzheimer's diseaseF Forette, T Hoover, S Gracon, et al.
Revue Neurologique|October 26, 2005
[Consensus statement on severe dementia]B Vellas, S Gauthier, H Allain, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2005
[Consensus statement on severe dementia]B Vellas, S Gauthier, H Allain, et al.
The Journal of Nutrition, Health & Aging|October 14, 2005
Consensus statement on dementia of Alzheimer type in the severe stageB Vellas, S Gauthier, H Allain, et al.
Pageof 19